J Cardiovasc Ultrasound.  2016 Mar;24(1):64-67. 10.4250/jcu.2016.24.1.64.

Abnormal Myocardial Blood Flow Reserve Observed in Cardiac Amyloidosis

• Nam MC
• Nel K
• Senior R
• Greaves K

• KMID: 2160998
• DOI: http://doi.org/10.4250/jcu.2016.24.1.64

Abstract

We performed real-time myocardial contrast echocardiography on a patient with cardiac amyloidosis and previous normal coronary angiography presenting with atypical chest pain to assess myocardial blood flow reserve (MBFR). Myocardial contrast echocardiography was performed and flash microbubble destruction and replenishment analysis was used to calculate myocardial blood flow. Dipyridamole was used to achieve hyperemia. MBFR was derived from the ratio of peak myocardial blood flow at hyperemia and rest. The results show a marked reduction in MBFR in our patient. Previous reports of luminal obstruction of intramyocardial rather than epicardial vessels by amyloid deposition may be causing microvascular dysfunction.

Keyword

Myocardial blood flow; Myocardial blood flow reserve; Contrast echocardiography; Cardiac amyloidosis; Echocardiography

MeSH Terms

Amyloidosis*
Chest Pain
Coronary Angiography
Dipyridamole
Echocardiography
Humans
Hyperemia
Microbubbles
Phenobarbital
Plaque, Amyloid
Dipyridamole
Phenobarbital

Figure

• 

  Fig. 1 Cardiac MR four chamber view showing biatrial and biventricular subendocardial delayed enhancement in keeping with a diagnosis of cardiac amyloidosis.

• 

  Fig. 2 Replenishment curves following bubble destruction using high amplitude ultrasound pulse at rest (A) and post-dipyridamole (stress) (B). A normal study curve has also been plotted for comparison, taken from previous published data by our group.5) Peak video intensity A is proportional to and therefore representative of blood volume. Gradient β (dB/s) represents peak blood velocity.

• 

  Fig. 3 Real-time myocardial contrast echo images showing bubble replenishment at rest and stress with a normal study for comparison. Each number in top left of image represents number of frames post bubble destruction. Notice bubble replenishment is more rapid and homogenous in the normal study compared to our patient both at rest and stress.

Reference

1. Narang R, Chopra P, Wasir HS. Cardiac amyloidosis presenting as ischemic heart disease. A case report and review of literature. Cardiology. 1993; 82:294–300.

2. Neben-Wittich MA, Wittich CM, Mueller PS, Larson DR, Gertz MA, Edwards WD. Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. Am J Med. 2005; 118:1287.

3. Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008; 51:1022–1030.

4. Wei K, Ragosta M, Thorpe J, Coggins M, Moos S, Kaul S. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation. 2001; 103:2560–2565.

5. Rana O, Byrne CD, Kerr D, Coppini DV, Zouwail S, Senior R, Begley J, Walker JJ, Greaves K. Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation. 2011; 124:1548–1556.

6. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007; 356:830–840.

7. Mueller PS, Edwards WD, Gertz MA. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med. 2000; 109:181–188.

8. Apridonidze T, Steingart RM, Comenzo RL, Hoffman J, Goldsmith Y, Bella JN, Landau H, Liu JE. Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis. Am J Cardiol. 2012; 110:1180–1184.

9. Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, Nihoyannopoulos P. Contrast echocardiography: evidencebased recommendations by European Association of Echocardiography. Eur J Echocardiogr. 2009; 10:194–212.

10. Al Suwaidi J, Velianou JL, Gertz MA, Cannon RO 3rd, Higano ST, Holmes DR Jr, Lerman A. Systemic amyloidosis presenting with angina pectoris. Ann Intern Med. 1999; 131:838–841.

11. Abdelmoneim SS, Bernier M, Bellavia D, Syed IS, Mankad SV, Chandrasekaran K, Pellikka PA, Mulvagh SL. Myocardial contrast echocardiography in biopsy-proven primary cardiac amyloidosis. Eur J Echocardiogr. 2008; 9:338–341.